Mauna Kea Technologies SA's latest marketcap:
As of 04/30/2026, Mauna Kea Technologies SA's market capitalization has reached $20.39 M. According to our data, Mauna Kea Technologies SA is the 37893th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 20.39 M |
| Revenue (ttm) | 10.42 M |
| Net Income (ttm) | 12.6 M |
| Shares Out | 94.87 M |
| EPS (ttm) | 0 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 04/22/2026 |
Mauna Kea Technologies SA's yearly market capitalization.
| Date | Market Cap(€) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 06/02/2026 | €33.55 M | $39.54 M | 383.82% | n/a |
| 12/31/2025 | €6.94 M | $8.05 M | -38.97% | 38008 |
| 12/31/2024 | €11.36 M | $11.76 M | -50.36% | 37196 |
| 12/29/2023 | €22.89 M | $25.27 M | 23.9% | 32298 |
| 12/30/2022 | €18.48 M | $19.77 M | -45.41% | 32671 |
| 12/31/2021 | €33.85 M | $38.47 M | -15.77% | 29129 |
| 12/31/2020 | €40.19 M | $49.08 M | -3.58% | 24806 |
| 12/31/2019 | €41.68 M | $46.73 M | -17.57% | 22285 |
| 12/31/2018 | €50.56 M | $57.97 M | -49.13% | 20180 |
| 12/29/2017 | €99.4 M | $119.22 M | 72.08% | 17073 |
Company Profile
About Mauna Kea Technologies SA
Mauna Kea Technologies SA is a leading medical device company specializing in innovative imaging solutions for healthcare professionals worldwide.
Key Offerings
The company develops and markets advanced medical devices across multiple specialties, including:
- Gastroenterology
- Pulmonology
- Urology
Flagship Product
Mauna Kea's premier offering is the Cellvizio platform, a cutting-edge real-time in vivo cellular imaging system. This technology empowers physicians to:
- Track disease progression over time
- Evaluate immediate tissue reactions
- Classify ambiguous areas
- Guide surgical procedures with precision
Company Background
Founded in 2000, Mauna Kea Technologies maintains its headquarters in Paris, France, while serving medical markets across Europe and internationally.
Frequently Asked Questions
-
What is Mauna Kea Technologies SA's (EPA-ALMKT) current market cap?As of 04/30/2026, Mauna Kea Technologies SA (including the parent company, if applicable) has an estimated market capitalization of $20.39 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Mauna Kea Technologies SA (EPA-ALMKT) rank globally by market cap?Mauna Kea Technologies SA global market capitalization ranking is approximately 37893 as of 04/30/2026. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.